Breaking News
January 24, 2018 - Study illustrates role of specific antibodies in protection against influenza
January 24, 2018 - Curcumin could provide meaningful cognitive benefits, study suggests
January 24, 2018 - Tenax Therapeutics Announces Plan to Develop Levosimendan for a Pulmonary Hypertension Indication with No FDA Approved Therapies
January 24, 2018 - EndoBreak: Obesity in 2018; Diabetes Risks in Pregnancy
January 24, 2018 - Recommendations to improve the quality of ultrasound imaging in obstetrics and gynecology
January 24, 2018 - Sensory feedback facilitates enhanced brainwave control of portable hand-exoskeleton
January 24, 2018 - Innovative system helps medical staff to accurately evaluate patients’ risk of falling
January 24, 2018 - Porvair Sciences to showcase microplate and chromatography products at Analytica 2018
January 24, 2018 - Children with cochlear implant learn words faster than kids with normal hearing
January 24, 2018 - Ionis’ Inotersen NDA Accepted for Priority Review by the FDA
January 24, 2018 - Abuse-Deterrent Opioid No Help in Australia
January 24, 2018 - Maternal mortality rates are on the rise, but more accurate estimates are needed
January 24, 2018 - New essential oil inhaler facilitates pain management
January 24, 2018 - USPSTF: Insufficient Evidence to Screen Kids for Scoliosis
January 24, 2018 - Team develops method to identify seizure-causing regions in the brain
January 24, 2018 - New report takes comprehensive look at health effects of e-cigarettes
January 24, 2018 - Researchers develop new indicator for assessing active aging
January 24, 2018 - Research highlights decreasing trend in traditional hysterectomy
January 24, 2018 - Computer-based speech analysis has potential to improve prediction of psychosis
January 24, 2018 - New family of FFPE reagent kits launched by Beckman Coulter Life Sciences
January 24, 2018 - Researchers use epigenetic signatures to advance diagnosis for neurodevelopmental disorders
January 24, 2018 - EPI report reveals air quality as major environmental threat to public health
January 23, 2018 - How to Fight the Flu This Season
January 23, 2018 - Mixed Data for Fatty Acid Intake and Glaucoma
January 23, 2018 - The brains of jazz and classical pianists work differently
January 23, 2018 - Scientists identify protein biomarkers to track patients with Hutchinson-Gilford progeria syndrome
January 23, 2018 - Exercise could extend the life expectancy of breast cancer survivors, study states
January 23, 2018 - Researchers show association between microbiome and cancer-related blood infections
January 23, 2018 - Site Sat Dormant for 10 Years. Now It’s Live Again.
January 23, 2018 - FDA’s program to speed up drug approval shaved nearly a year off the process
January 23, 2018 - Study reveals key challenges and frustrations associated with current RTSM/IRT solutions
January 23, 2018 - Researchers unravel function of protein ‘smallish’
January 23, 2018 - Infants born in withdrawal due to opioid exposure in utero show abnormalities
January 23, 2018 - Researchers block common siren call of glioblastoma and metastatic breast cancer
January 23, 2018 - FDA Accepts New Drug Applications for Merck’s Doravirine, the Company’s Investigational Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), for Treatment of HIV-1 Infection
January 23, 2018 - Six Concerns About Practice Consolidation
January 23, 2018 - How Alzheimer’s Changes the Brain
January 23, 2018 - Pharmaceutical stirs outrage over price hike for brain tumor drug
January 23, 2018 - University under fire for off-the-grid herpes vaccine experiments
January 23, 2018 - Gastric environment permanently changes in the presence of Helicobacter pylori infection
January 23, 2018 - Scientists take tissue-engineering approach to improve healing related to skeletal system
January 23, 2018 - Consumption of dietary fiber can prevent obesity and metabolic syndrome, study shows
January 23, 2018 - FDA Alert: Multiple Drug Products by Flawless Beauty: Recall
January 23, 2018 - Rhymes with Amyloid: That’s Improbable!
January 23, 2018 - CLCN2-related leukoencephalopathy – Genetics Home Reference
January 23, 2018 - Can road salt and other pollutants disrupt our circadian rhythms?
January 23, 2018 - ‘Depression literacy’ program encourages many teens to seek adult help
January 23, 2018 - New initiative seeks to transform the way people live with dementia
January 23, 2018 - Isosec introduces first Virtual Smartcard for NHS Trusts and clinicians
January 23, 2018 - New report reveals rapid growth in Vietnam pharmaceutical market
January 23, 2018 - Obamacare Led to Rise in Breast Cancer Screening
January 23, 2018 - Bariatric Tx Bests Usual Care for Long-Term Health
January 23, 2018 - Keep Your Dogs and Cats Safe From Holiday Hazards
January 23, 2018 - New AI technology significantly improves human kidney analysis
January 23, 2018 - In Trump’s first year, anti-abortion forces make strides despite setbacks
January 23, 2018 - Small PFS Bump in Gastric/GEJ Cancer
January 23, 2018 - Defending against environmental stressors may shorten lifespan
January 23, 2018 - Researchers create cavitation bubbles to remove dental plaque
January 23, 2018 - Discovery offers fresh perspective on how the brain keeps its balance
January 23, 2018 - Opioid exposure linked to physical abnormalities in newborns
January 23, 2018 - Study identifies genes involved in latent asymptomatic state of breast cancer metastases
January 23, 2018 - Kala Pharmaceuticals Announces New Drug Application for Inveltys (KPI-121 1%) Has Been Accepted for Review by the U.S. Food and Drug Administration
January 23, 2018 - Closer Look at Household Contacts Finds More TB Cases
January 23, 2018 - Type 1 IFNs may mediate Zika pregnancy complications
January 23, 2018 - Anti-inflammatory pill could help make vaccines more effective for the elderly
January 23, 2018 - New discovery sheds light on iron-restricted anemia that causes fatigue in millions
January 23, 2018 - BMG LABTECH’s Australian office celebrates 20 years of innovation and growth in APAC region
January 23, 2018 - FDA Alert: Basic Drugs Brand of Senna Laxative by Magno-Humphries Laboratories: Recall
January 23, 2018 - Chronic Opioid Use High Among IBD Patients
January 23, 2018 - New long-acting, less-toxic HIV drug suppresses virus in humanized mice
January 23, 2018 - Findings provide better understanding of cognitive inflexibility in Fragile X Syndrome
January 23, 2018 - Powerful anti-oxidant can stop progression of fatty liver disease in young mice
January 23, 2018 - Marijuana use does not lower probability of conception, study shows
January 23, 2018 - Study shows value of occupational therapy in the lives of young adults with diabetes
January 23, 2018 - Chinese researchers develop multifunctional vehicle to transport gene therapeutics
January 23, 2018 - Researchers seek to understand effect of very low birth weight on the brain
January 23, 2018 - Be a Savvy Supermarket Shopper
January 23, 2018 - NIH Striving to Avoid False Hope in Chronic Fatigue
January 23, 2018 - Occupational Stress
January 23, 2018 - PrEP could make US easily hit its 2020 HIV prevention goal, study finds
DNA-level biomarker can are expecting general survival for uncommon mind tumors

DNA-level biomarker can are expecting general survival for uncommon mind tumors

image_pdfDownload PDFimage_print

MGMT promoter methylation standing—knowledge accumulated at a DNA-level—can lend a hand are expecting general survival for sufferers with a unprecedented type of mind most cancers referred to as anaplastic astrocytoma, in keeping with a brand new research from The Ohio State College Complete Most cancers Heart – Arthur G. James Most cancers Sanatorium and Richard J. Solove Analysis Institute (OSUCCC – James).

The objective of this learn about used to be to decide the choice of sufferers with sure MGMT promoter methylation standing and its importance as a way of predicting survival results for sufferers with anaplastic astrocytomas. Erica Bell, PhD, assistant professor of radiation oncology served as first writer of the learn about. Arnab Chakravarti, MD, chair of radiation oncology on the OSUCCC – James, used to be senior writer and major investigator.

MGMT is a famous DNA restore gene and identified biomarker in grade four glioblastoma mind tumors, on the other hand, knowledge on its prognostic worth in different grade 2 and grade three kinds of mind tumors has been unclear. MGMT promoter methylation used to be calculated the use of the MGMT-STP27 style on this learn about.

“The scientific neighborhood has suspected that MGMT standing may well be used as a biomarker for predicting general survival in those sufferers, however get entry to to a big set of well-controlled scientific knowledge and paired specimens to verify this used to be missing,” says Bell. “Our learn about represents the primary knowledge confirming that MGMT promoter methylation standing can be utilized as an unbiased biomarker for predicting general survival in grade three tumors.”

She notes that this data will lend a hand oncologists determine sufferers much less most probably to reply to remedy according to the biology in their tumors and design higher scientific trials.

Bell will provide the findings (Summary No. 2781) on Sept. 26, 2017, at the once a year assembly of the American Society for Radiation Oncology (ASTRO) in San Francisco, the place she may also obtain some of the 2017 “Very best of ASTRO” awards.

Find out about Design and Effects

For this learn about, researchers analyzed knowledge from a countrywide cooperative staff trial (RTOG 9813) that enrolled 196 high-risk sufferers with anaplastic astrocytoma. Sufferers had been randomized into certainly one of two remedy hands: radiation treatment plus nitrosourea or radiation treatment and temozolomide.

MGMT promoter methylation standing used to be calculated for 58 sufferers – 62 % of sufferers examined sure for the biomarker. Bell and co-workers then particularly analyzed MGMT promoter methylation in correlation with general and progression-free survival results. Sufferers who had the MGMT biomarker additionally had upper general survival when compared with sufferers whose tumors didn’t raise this biomarker. No vital distinction in progression-free survival used to be noticed, even supposing there used to be a pattern towards importance.

Bell says your next step is to broaden higher predictive biomarker fashions that incorporate all identified markers, now not simply MGMT.

“This may increasingly lend a hand us higher perceive which explicit sufferers don’t seem to be doing effectively on standard-of-care and sign up the ones sufferers to scientific trials that can give us the most productive probability of most cancers keep watch over,” she provides. “If we perceive which sufferers don’t seem to be doing effectively on usual of care, we will be able to in point of fact focal point on designing explicit scientific trials to lend a hand the ones sufferers reach higher general survival.”

Discover additional:
A brand new prognostic classification would possibly lend a hand scientific decision-making in glioblastoma

Equipped through:
Ohio State College Clinical Heart

Tagged with:

About author

Related Articles